BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: Potential interaction between BRCA1 and Sp1

Molecular Genetics and Metabolism

Volumn 69, Issue 2, 2000, Pages 130-136

  Maor, Sharon B ^a   Abramovitch, Shirley ^a   Erdos, Mike R ^a   Brody, Lawrence C ^b   Werner, Haim ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

BRCA1; IGF I receptor; Sp1; Tumor suppressor

Indexed keywords

SOMATOMEDIN C;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GROWTH; DROSOPHILA; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0034033970     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2958     Document Type: Article

References (47)

1. LeRoith D, Werner H, Beitner-Johnson D, Roberts C T Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrine Rev. 16:1995;143-163.
2. Werner H, Woloschak M, Stannard B, Shen-Orr Z, Roberts C T Jr, LeRoith D. Insulin-like growth factor receptor: Molecular biology, heterogeneity, and regulation. LeRoith D. Insulin-like Growth Factors: Molecular and Cellular Aspects. 1991;17-47 CRC Press, Boca Raton.
3. Cohick W S, Clemmons D R. The insulin-like growth factors. Ann Rev Physiol. 55:1993;131-153.
4. Baker J, Liu J-P, Robertson E J, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 75:1993;73-82.
5. Liu J-P, Baker J, Perkins A S, Robertson E J, Estratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 75:1993;59-72.
6. Pietrzkowski Z, Lammers R, Carpenter G, Soderquist A M, Limardo M, Phillips P D, Ullrich A, Baserga R. Constitutive expression of insulin-like growth factor I and insulin-like growth factor I receptor abrogates all requirements for exogenous growth factors. Cell Growth Diff. 3:1992;199-205.
7. Werner H, LeRoith D. The role of the insulin-like growth factor system in human cancer. Adv Cancer Res. 68:1996;183-223.
8. Baserga R, Sell C, Porcu P, Rubini M. The role of the IGF-I receptor in the growth and transformation of mammalian cells. Cell Prolif. 27:1994;63-71.
9. Sell C, Rubini M, Rubin R, Liu J-P, Efstratiadis A, Baserga R. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc Natl Acad Sci USA. 90:1993;11217-11221.
10. Peyrat J-P, Bonneterre J, Beuscart R, Dijane J, Demaille A. Insulin-like growth factor I receptors in human breast cancer and their relation to estradiol and progesterone receptors. Cancer Res. 48:1988;6429-6436.
11. Arteaga C L, Osborne C K. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Cancer Res. 49:1989;6237-6241.
12. Hankinson S E, Willett W C, Colditz G A, Hunter D J, Michaud D S, Deroo B, Rosner B. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet. 351:1998;1393-1396.
13. Miki Y, Swensen J, Shattuck-Eidens D, Futreal P A, Harshman K, Tavtigian S, Liu Q. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-71.
14. Holt J T, Thompson M E, Szabo C, Robinson-Benion C, Arteaga C L, King M C, Jensen R A. Growth retardation and tumour inhibition by BRCA1. Nat Genet. 12:1996;298-301.
15. Thompson M E, Jensen R A, Obermiller P S, Page D L, Holt J T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet. 9:1995;444-450.
16. Rao V N, Shao N, Ahmad M, Reddy E SP. Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts. Oncogene. 12:1996;523-528.
17. Jin Y, Xu X L, Yang M C, Wei F, Ayi T C, Bowcock A M, Baer R. Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. Proc Natl Acad Sci USA. 94:1997;12075-12080.
18. Scully R, Chen J, Ochs R L, Keegan K, Hoekstra M, Feunteun J, Livingston D M. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell. 90:1997;425-435.
19. Maul G G, Jensen D E, Ishov A M, Herlyn M, Rauscher F J III. Nuclear redistribution of BRCA1 during viral infection. Cell Growth Diff. 9:1998;743-755.
20. Scully R, Anderson S F, Chao D M, Wei W, Ye L, Young R A, Livingston D M, Parvin J D. BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci USA. 94:1997;5605-5610.
21. Chapman M S, Verma I M. Transcriptional activation by BRCA1. Nature. 382:1996;678-679.
22. Monteiro A NA, August A, Hanafusa H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc Natl Acad Sci USA. 93:1996;13595-13599.
23. Werner H, Re G G, Drummond I A, Sukhatme V P, Rauscher F J III, Sens D A, Garvin A J, LeRoith D, Roberts C T Jr. Increased expression of the insulin-like growth factor-I receptor gene, IGFIR, in Wilms' tumor is correlated with modulation of IGFIR promoter activity by the WT1 Wilms' tumor gene product. Proc Natl Acad Sci USA. 90:1993;5828-5832.
24. Werner H, Rauscher F J III, Sukhatme V P, Drummond I A, Roberts C T Jr, LeRoith D. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. J Biol Chem. 269:1994;12577-12582.
25. Werner H, Shen-Orr Z, Rauscher F J III, Morris J F, Roberts C T Jr, LeRoith D. Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression. Mol Cell Biol. 15:1995;3516-3522.
26. Werner H, Bach M A, Stannard B, Roberts C T Jr, LeRoith D. Structural and functional analysis of the insulin-like growth factor I receptor gene promoter. Mol Endocrinol. 6:1992;1545-1558.
27. Fan S, Wang J-A, Yuan R, Ma Y, Meng Q, Erdos M R, Pestell R G, Yuan F, Auborn K J, Goldberg I D, Rosen E M. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science. 284:1999;1354-1356.
28. Beitner-Johnson D, Werner H, Roberts C T Jr, LeRoith D. Regulation of insulin-like growth factor I receptor gene expression by Sp1: Physical and functional interactions of Sp1 at GC boxes and at a CT element. Mol Endocrinol. 9:1995;1147-1156.
29. Werner H, Stannard B, Bach M A, LeRoith D, Roberts C T Jr. Cloning and characterization of the proximal promoter region of the rat insulin-like growth factor I (IGF-I) receptor gene. Biochem Biophys Res Commun. 169:1990;1021-1027.
30. Courey A J, Tjian R. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell. 55:1988;887-898.
31. Surmacz E, Guvakova M, Nolan M, Nicosia R, Sciacca L. Type I insulin-like growth factor receptor function in breast cancer. Breast Cancer Res Treat. 47:1998;255-267.
32. Osborne C K, Clemmons D R, Arteaga C L. Regulation of breast cancer growth by insulin-like growth factors. J Steroid Biochem Mol Biol. 37:1990;805-809.
33. Jammes H, Peyrat J P, Ban E, Vilain M O, Haour F, Djiane J, Bonneterre J. Insulin-like growth factor I receptors in human breast tumour: Localization and quantification by histo-autoradiographic analysis. Br J Cancer. 66:1992;248-253.
34. Resnic J L, Reichart D B, Huey K, Webster N JG, Seely B L. Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer. Cancer Res. 58:1998;1159-1164.
35. Turner B C, Haffty B G, Narayanann L, Yuan J, Havre P A, Gumbs A, Kaplan L, Burgaud J-L, Carter D, Baserga R, Glazer P M. IGF-I receptor and cyclin D1 expression influence cellular radiosensitivity and local breast cancer recurrence after lumpectomy and radiation. Cancer Res. 57:1997;3079-3083.
36. Arteaga C L, Kitten L J, Coronado E B, Jacobs S, Kull F C Jr. Allred DC, Osborne CK. J Clin Invest. 84:1989;1418-1423.
37. Mamula P W, Goldfine I D. Cloning and characterization of the human insulin-like growth factor-I receptor gene 5′-flanking region. DNA Cell Biol. 11:1992;43-50.
38. Smale S T, Baltimore D. The "initiator" as a transcription control element. Cell. 57:1989;103-113.
39. Werner H, Woloschak M, Adamo M, Shen-Orr Z, Roberts C T Jr, LeRoith D. Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA. 86:1989;7451-7455.
40. Andres J L, Fan S, Turkel G J, Wang J-A, Twu N-F, Yuan R-Q, Lamszus K, Goldberg I D, Rosen E M. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents. Oncogene. 16:1998;2229-2241.
41. WAF1/CiP1. Nature. 389:1997;187-190.
42. Harkin D P, Bean J M, Miklos D, Song Y H, Truong V B, Englert C, Christians F C, Ellisen L W, Maheswaran S, Oliner J D, Haber D A. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell. 97:1999;575-586.
43. Werner H, Karnieli E, Rauscher F J III, LeRoith D. Wild type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA. 93:1996;8318-8323.
44. Ohlsson C, Kley N, Werner H, LeRoith D. p53 regulates IGF-I receptor expression and IGF-I induced tyrosine phosphorylation in an osteosarcoma cell line: Interaction between p53 and Sp1. Endocrinology. 139:1998;1101-1107.
45. Courey A J, Tjian R. Mechanisms of transcriptional control as revealed by studies of human transcription factor Sp1. McKnight S, Yamamoto K. Transcriptional Regulation. 1992;743-769 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
46. Kim S J, Onwuta U S, Lee Y I, Li R, Botchan M R, Robbins P D. The retinoblastoma gene product regulates Sp1-mediated transcription. Mol Cell Biol. 12:1992;2455-2463.
47. Mukhopadhyay D, Knebelmann B, Cohen H T, Ananth S, Sukhatme V P. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity. Mol Cell Biol. 17:1997;5629-5639.